Muscular Dystrophy Whole Blood

<h2>Muscular Dystrophy Whole Blood for Research</h2>
Muscular dystrophy encompasses a group of genetic disorders causing progressive muscle weakness and degeneration, most commonly linked to dystrophin gene mutations. Sanguine collects fresh whole blood from IRB-consented donors with a clinically confirmed muscular dystrophy diagnosis for neuromuscular and genetic disease research.
<h3>Product Features</h3>
<ul><li>Fresh whole blood from clinically diagnosed muscular dystrophy donors</li><li>Custom anticoagulants and collection tubes available</li><li>Same-day collection and shipment</li><li>Research Use Only (RUO)</li></ul>
<h3>De-identified Donor Data</h3>
<ul><li>Physician-confirmed diagnosis, including subtype and genetic testing results where available</li><li>Demographics: age, sex assigned at birth, ethnicity</li><li>Relevant medical and family history</li></ul>
<h3>Applications</h3>
<ul><li>Dystrophin and related gene variant research</li><li>Muscle degeneration biomarker studies</li><li>Gene expression and transcriptomic analysis</li><li>Gene therapy and exon-skipping response research</li></ul>
<h3>Compliance and Quality</h3>
<ul><li>IRB-approved protocols and electronic informed consent</li><li>HIPAA-compliant donor data handling</li></ul>
<h3>Ordering and Customization</h3>
Muscular dystrophy whole blood is available in standard and custom volumes. Email <a href=”mailto:learnmore@sanguinebio.com”>learnmore@sanguinebio.com</a> for international orders or documentation requirements.